Allogeneic Limbal Transplants Integrate into the Corneal Surface and Lead to an Improved Visual Acuity.
Christiane KesperJoana HeinzelmannAnja ViestenzThomas HammerSabine FojaMarlene SteinArne ViestenzPublished in: Journal of clinical medicine (2023)
Limbal stem cell deficiency (LSCD) severely impairs vision and can lead to blindness. LSCD causes include chemical burns, infections, multiple previous operations and congenital malformations. Allogeneic limbal transplantation is a procedure for treating LSCD where prepared limbal tissue is attached using a double running suture during allogeneic penetrating keratoplasty (PKP). A total of 22 patients underwent ALT surgery between February 2019 and June 2022 at the University Hospital Halle (Saale). Regular follow-up was performed postoperatively every three months and included visual acuity testing, pressure measurement, slit lamp microscopic examination, fundoscopy, corneal topography and anterior segment optical coherence tomography (AS-OCT). The mean patient age was 69.5 years, and the mean follow-up was 19 months. All included patients had LSCD and multiple previous surgeries. Patient LSCD etiology was 59% infectious and 41% traumatic. ALTs integrated into corneal surfaces in all patients, demonstrated on AS-OCT. Since most patients initially received allogeneic limbal transplants, none of the operated eyes had surgical complications. Overall, visual acuity improved postoperatively from an initial 2.06 to 1.44 logarithm of the minimum angle of resolution (logMAR). Allogeneic limbal transplantation can be used to treat LSCD and its integration into the surrounding corneal tissue can be observed on AS-OCT.
Keyphrases
- optical coherence tomography
- end stage renal disease
- stem cell transplantation
- ejection fraction
- stem cells
- newly diagnosed
- chronic kidney disease
- bone marrow
- prognostic factors
- minimally invasive
- peritoneal dialysis
- spinal cord injury
- staphylococcus aureus
- high dose
- mesenchymal stem cells
- diabetic retinopathy
- low dose
- mass spectrometry
- escherichia coli
- cell therapy
- coronary artery disease
- quantum dots
- coronary artery bypass
- sensitive detection